OAT Agrio (4979) · FactAdvanced
Contract Research in Plants Using Genome Editing and Genetic Analysis
First written in FY2024-H1. 1 of 2 entries say "Advanced", first in FY2024. Latest entry: FY2024.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Contract Research Business for Plant Genome Editing and Genetic AnalysisA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2024AdvancedAnnual report
「国内子会社でバイオスティミュラント製品の製造並びに肥料の製造・販売を行う旭化学工業株式会社や、ゲノム編集や遺伝子解析など植物の受託研究を行う株式会社インプランタイノベーションズも前年比で増収増益となりました。」
植物のゲノム編集・遺伝子解析等の受託研究を行うインプランタイノベーションズが、2024年度に前年比で増収増益となった。 - FY2024-H1First statedAnnual report
「旭化学工業株式会社, a domestic subsidiary that manufactures biostimulant products and manufactures and sells fertilizers, and 株式会社インプランタイノベーションズ, which conducts contract research on plants using genome editing and genetic analysis, both performed well in terms of revenue year on year.」
株式会社インプランタイノベーションズ was first disclosed as a standalone domestic subsidiary conducting contract research on plants, including genome editing and genetic analysis.